YOUR BUSINESS AUTHORITY
Springfield, MO
YOUR BUSINESS AUTHORITY
Springfield, MO
The Food and Drug Administration has approved a new schizophrenia drug from Bristol Myers Squibb.
Called Cobenfy, the drug is the first novel type of treatment for the mental disorder in more than seven decades, according to CNBC.
Bristol Myers Squibb expects the twice-daily pill to become available in October.
Read more from CNBC.
This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.
Banker pleads guilty to fraud scheme
Longtime employee sues Ozarks Tech, alleges retaliation
Cavender’s opens hat shop in southeast Springfield
Caterpillar to acquire John Fabick Tractor Co.
Eric Schmitt introduces Modern Skies Act
Springfield airport to cut the ribbon on $35M in construction projects